| 1 |
33992954 | Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6. | 2021 Aug |
1 |
| 2 |
27208383 | Establishment of In Silico Prediction Models for CYP3A4 and CYP2B6 Induction in Human Hepatocytes by Multiple Regression Analysis Using Azole Compounds. | 2016 Aug |
3 |
| 3 |
25868557 | Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. | 2015 Jun |
1 |
| 4 |
20149798 | Structural basis of human CYP51 inhibition by antifungal azoles. | 2010 Apr 9 |
1 |
| 5 |
20501634 | The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6. | 2010 Sep 1 |
1 |
| 6 |
18563875 | How do azoles inhibit cytochrome P450 enzymes? A density functional study. | 2008 Dec 18 |
11 |
| 7 |
17954932 | Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. | 2007 Dec 14 |
1 |
| 8 |
17073778 | Protein dynamics and imidazole binding in cytochrome P450 enzymes. | 2006 Dec |
1 |
| 9 |
17073780 | CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen. | 2006 Dec |
1 |
| 10 |
11469860 | Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF. | 2001 Aug 3 |
1 |
| 11 |
2091733 | Biochemical basis for the activity and selectivity of oral antifungal drugs. | 1990 Sep |
2 |